voriconazole has been researched along with Candidiasis, Oral in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, JV; Miltenberger, R; Müller, FM; Salvenmoser, S; Staudigel, A; Tredup, A | 1 |
| Boehler, C; Cianferani, S; Dartevelle, P; Ehlinger, C; Haïkel, Y; Marban, C; Metz-Boutigue, MH; Rabineau, M; Strub, JM; Westermann, B; Zaet, A | 1 |
| Arora, V; Dewan, P; Gomber, S | 1 |
| Brusca, MI; Iovannitti, CA; Jewtuchowicz, VM; Malzone, MC; Mujica, MT; Pola, SJ; Rosa, AC; Sordelli, N | 1 |
| Aguirre, JM; Carrillo-Muñoz, AJ; Eraso, E; Gaitán-Cepeda, LA; Quindós, G; Sánchez Vargas, LO | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW | 1 |
| Andreadis, D; Antoniades, D; Arsenis, G; Belazi, M; Destouni, E; Eliopoulou, C; Hini, S; Koussidou-Eremondi, T; Velegraki, A | 1 |
| Burn, AK; Coco, BJ; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Patterson, TF; Redding, SW; Rinaldi, MG | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Kalavsky, E; Krcmery, V; Liskova, A; Shahum, A | 1 |
| Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA | 1 |
| Ruhnke, M; Schmidt-Westhausen, A; Trautmann, M | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Diehl, V; Fätkenheuer, G; Hegener, P; Ruhnke, M; Troke, PF | 1 |
| Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A | 1 |
16 other study(ies) available for voriconazole and Candidiasis, Oral
| Article | Year |
|---|---|
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Germany; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Oropharynx; Vitis | 2007 |
D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Cell Division; Cell Line; Chromogranin A; Humans; Microbial Sensitivity Tests; Peptide Fragments; Peptides; Voriconazole | 2018 |
Ventricular Tachycardia: A Rare Side Effect of Voriconazole.
Topics: Anemia, Aplastic; Antifungal Agents; Candidiasis, Oral; Child; Electrocardiography; Humans; Male; Tachycardia, Ventricular; Voriconazole | 2017 |
Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Topics: Adolescent; Adult; Aged; Argentina; Candida; Candidiasis, Oral; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Periodontal Pocket; Phenotype; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2008 |
In vitro activity of voriconazole against Mexican oral yeast isolates.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Mexico; Microbial Sensitivity Tests; Mouth; Pharynx; Pyrimidines; Triazoles; Voriconazole | 2010 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole | 2012 |
Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Topics: Adult; Aged; Antifungal Agents; Azoles; Candida; Candidiasis, Oral; Carcinoma, Squamous Cell; Cranial Irradiation; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Pyrimidines; Stomatitis; Triazoles; Voriconazole | 2004 |
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cambodia; Candida; Candidiasis, Oral; Child; Drug Resistance, Multiple, Fungal; Humans; Oropharynx; Pharyngeal Diseases; Pyrimidines; Saccharomyces; Triazoles; Voriconazole | 2007 |
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth; Pyrimidines; Triazoles; Voriconazole | 1997 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 1998 |
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 1999 |